or Try an Advanced Search...

    Technical Analysis for MIST - Milestone Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    F 1.60 -3.03% -0.05
    MIST closed down 3.03 percent on Wednesday, May 1, 2024, on 27 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MIST trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    50 DMA Resistance Bearish -3.03%
    Lower Bollinger Band Walk Weakness -3.03%
    Outside Day Range Expansion -3.03%
    Lower Bollinger Band Touch Weakness -3.03%
    Lower Bollinger Band Walk Weakness 1.91%
    Stochastic Reached Oversold Weakness 1.91%
    Lower Bollinger Band Touch Weakness 1.91%
    Older End-of-Day Signals for MIST ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 4 hours ago
    Gap Down Partially Closed about 6 hours ago
    Gap Down Closed about 6 hours ago
    Gapped Down (Partial) about 7 hours ago
    50 DMA Resistance about 7 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MIST Chart by TradingView
    Basic chart:

    Profile

    Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina. The company was founded in 2003 and is headquartered in Montréal, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cardiology Cardiac Arrhythmia Atrial Fibrillation Angina Circulatory System Cardiovascular System Tachycardia Ventricular Tachycardia

    Is MIST a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 3 Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
    Apr 1 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
    Mar 21 Milestone Pharmaceuticals reports Q4 results
    Feb 29 Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference
    Feb 29 Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 29 Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants
    Feb 26 Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
    Jan 16 Down -43.64% in 4 Weeks, Here's Why Milestone Pharmaceuticals (MIST) Looks Ripe for a Turnaround
    Jan 2 Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
    Dec 27 Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
    See more MIST news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.48
    52 Week Low 1.35
    Average Volume 376,531
    200-Day Moving Average 2.35
    50-Day Moving Average 1.67
    20-Day Moving Average 1.68
    10-Day Moving Average 1.62
    Average True Range 0.12
    RSI (14) 45.36
    ADX 18.06
    +DI 13.18
    -DI 15.65
    Chandelier Exit (Long, 3 ATRs) 1.50
    Chandelier Exit (Short, 3 ATRs) 1.87
    Upper Bollinger Bands 1.83
    Lower Bollinger Band 1.53
    Percent B (%b) 0.24
    BandWidth 18.07
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0136
    Fundamentals Value
    Market Cap 53.57 Million
    Num Shares 33.5 Million
    EPS -1.38
    Price-to-Earnings (P/E) Ratio -1.16
    Price-to-Sales 12.28
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.74
    Resistance 3 (R3) 1.75 1.71 1.72
    Resistance 2 (R2) 1.71 1.67 1.70 1.71
    Resistance 1 (R1) 1.65 1.65 1.63 1.65 1.70
    Pivot Point 1.61 1.61 1.60 1.61 1.61
    Support 1 (S1) 1.56 1.58 1.54 1.55 1.50
    Support 2 (S2) 1.52 1.56 1.52 1.49
    Support 3 (S3) 1.47 1.52 1.48
    Support 4 (S4) 1.46